Being Heard Key for Women After Gender-Based Violence

This article originally appeared here.
Share this content:
Being Heard Key for Women After Gender-Based Violence
Being Heard Key for Women After Gender-Based Violence

TUESDAY, Sept. 12, 2017 (HealthDay News) -- For women who have experienced gender-based violence, feelings of being listened to and respected are important for defining a positive health care encounter, according to research published online Aug. 22 in the Journal of Clinical Nursing.

Inger Wallin Lundell, R.N., Ph.D., from Linköping University in Sweden, and colleagues describe encounters with health care professionals for women in Mexico who had experienced gender-based violence. Seven women underwent face-to-face interviews. The interviews were analyzed with inductive content analysis.

The researchers identified four categories in the analyses: feelings of guilt about being abused; feelings of being unimportant; feelings of taking up time; and feelings of being insecure. The importance of health care professionals taking time out of their busy schedules for women was emphasized. Women felt secure when treated with respect and genuine interest. Feelings of frustration and mistrust were elicited when the health care professionals did not meet these expectations.

"Feelings of being listened to and safety were considered important aspects in a positive encounter, whereas feeling a lack of time or interest often led to negative experiences such as frustration with and distrust of the health care system," the authors write. "These results imply that health care professionals may have deficiencies with regard to how these women are treated because these women do not feel that they receive the proper support."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »